University of Saskatchewan

April 19, 2014   

Fast Facts about INTERVAC

InterVac (International Vaccine Centre) is a $140 million vaccine research and development centre to be built at the University of Saskatchewan, next to VIDO and connected to it via a walkway. InterVac will develop vaccines to protect people and animals from the threat of emerging or persistent diseases such as avian influenza or tuberculosis. This new facility will be the first Containment Level 3 facility in Western Canada dealing with both human and large animal diseases. InterVac will enhance a cluster of world-class life sciences research capacity on the University of Saskatchewan campus that is unique in North America.

InterVac Overview

Contact Us

(image of Architect's
rendering of InterVac facility)

Architect's rendering of the new centre
AODBT in association with Smith Carter
 


Take now `

Please help us improve this website.

My relationship to the U of S is:

(check all that apply)

Current Faculty
Reseach Chair
Prospective Faculty    

Current Graduate Student
Prospective Graduate Student
Current Undergraduate
Student
Prospective Undergraduate
Student

Current Employee
Prospective Employee
Post-Doctoral Fellow    

Industry Partner
Media

Donor
Alumni

Other:   

Why did you come to the site today?

Comments?